GHRH and ovarian carcinoma: Surgical specimens of human prostate, breast, endometrial, and ovarian cancers were identified to contain GHRH mRNA [13], and a variety of human cancer lines and tumor samples express mRNAs encoding four possible splice variants (SVs) of GHRH-Rs with high-affinity binding sites for GHRH and its analogs [14].